Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients

被引：0
|
作者：
Watanabe, Fumiaki
Suzuki, Koichi
Endo, Yuhei
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构：
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
254
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical significance of MUC4 isoforms in pancreatic cancer patients
    Thompson, Christopher M.
    Cannon, Andrew
    Kshirsagar, Prakash
    Bhatia, Rakesh
    Batra, Surinder
    Kumar, Sushil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [22] Clinical significance of genetic alterations in plasma of colorectal cancer patients
    Lecomte, T
    Berger, A
    Micard, S
    Zinzindouhoue, F
    Landi, B
    Beaune, P
    Cugnenc, PH
    Laurent-Puig, P
    GASTROENTEROLOGY, 2001, 120 (05) : A160 - A160
  • [23] Prognostic significance of tissue factor in patients with pancreatic cancer: a systematic review protocol
    Li, Haiyuan
    Yu, Yang
    Shi, Qianling
    Chen, Xueping
    Zheng, Peng
    Wang, Dengfeng
    Tao, Pengxian
    Gu, Baohong
    Li, Xuemei
    Zhang, Tao
    Xiang, Lin
    Xi, Dayong
    Gao, Lei
    Maswikiti Ewetse, Paul
    Chen, Hao
    BMJ OPEN, 2020, 10 (09): : e037431
  • [24] Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non-Small Cell Lung Cancer
    Wang, Shuhang
    An, Tongtong
    Wang, Jie
    Zhao, Jun
    Wang, Zhijie
    Zhuo, Minglei
    Bai, Hua
    Yang, Lu
    Zhang, Yan
    Wang, Xin
    Duan, Jianchun
    Wang, Yuyan
    Guo, Qingzhi
    Wu, Meina
    CLINICAL CANCER RESEARCH, 2010, 16 (04) : 1324 - 1330
  • [25] Prognostic significance of plasma matrix metalloprotease-2 in pancreatic cancer patients
    Singh, Nidhi
    Gupta, Surabhi
    Pandey, Ravindra M.
    Sahni, Peush
    Chauhan, Shyam S.
    Saraya, Anoop
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 334 - 340
  • [26] The KRAS mutational spectrum and its clinical implications in pancreatic cancer
    Perelli, Luigi
    Genovese, Giannicola
    Draetta, Giulio F.
    CANCER CELL, 2024, 42 (09) : 1494 - 1496
  • [27] Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue
    Ako, Soichiro
    Nouso, Kazuhiro
    Kinugasa, Hideaki
    Dohi, Chihiro
    Matushita, Hiroshi
    Mizukawa, Sho
    Muro, Shinichiro
    Akimoto, Yutaka
    Uchida, Daisuke
    Tomoda, Takeshi
    Matsumoto, Kazuyuki
    Horiguchi, Shigeru
    Tsutsumi, Koichiro
    Kato, Hironari
    Okada, Hiroyuki
    PANCREATOLOGY, 2017, 17 (02) : 285 - 290
  • [28] Clinical significance of monitoring plasma concentrations of acetazolamide
    Inatani, M
    Tanihara, H
    Ogura, Y
    Yano, I
    Takayama, A
    Takano, M
    Inui, K
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 5075 - 5075
  • [29] CLINICAL SIGNIFICANCE OF THE KRAS MUTATION
    Beganovic, Sead
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2009, 9 : S17 - S20
  • [30] Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients
    Zhao, WL
    Wang, XF
    Qu, B
    Huang, XP
    Wang, HL
    CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 702 - 704
12345